Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 6

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 6
---
 |     | Advance, mobilize, and retain key talent that is fit for purpose with our evolving business needs |     | Rebuild processes end-to-end and deploy digital and AI to fundamentally  transform our business and simplify how we serve consumers and care providers |     | Expand beyond our Blue markets and integrate new businesses into our health plans and Carelon to improve quality and lower cost for customers |     | Be an active partner, going beyond the contract to create a real impact on health - together |
|                                  |     |                                                                                                   |     | Culture Connected to Strategy                                                                                                                          |     |                                                                                                                                               |     |                                                                                              |

| Values |

| 6 |

#### Proxy Summary

#### 2024 Performance Highlights
Elevance Health navigated a challenging and dynamic operating environment in 2024, taking strategic actions to deliver operational efficiencies and appropriately manage cost of care issues facing the industry. We invested to position Elevance Health for strong growth over the long term, including diligently executing on our growth strategy across our health benefits business, making significant progress in scaling for growth in Carelon, our health services division, and expanding our CarelonRx pharmacy customer base while diversifying its value proposition. In 2024, we completed the acquisitions of a home healthcare company and an ambulatory and home infusion services company, and also partnered to create a national care delivery platform focused on expanding access to comprehensive primary care, all of which continued to expand our healthcare services and capabilities.

| Members                    |     | 45.7 Million                                        |
| Cash Dividends Paid        |     | $6.52 per share                                     
 (up 10.1% from 2023)                                |
| Income before Income Taxes |     | $7.9 Billion                                        |
| Operating Gain*            |     | $7.9 Billion                                        |
| Returned to Shareholders   |     | $4.4 Billionthrough share repurchases and dividends |

* Please refer to the GAAP reconciliation table in Annex A for the reconciliation of these measures to GAAP.

#### 2025 Proxy Statement7

#### Proxy Summary

#### Corporate Impact Highlights
We are committed to the health and well-being of the world around us and are proud of the impact we make in pursuing our purpose of improving the health of humanity. Our Governance Committee monitors our corporate social responsibility and environmental sustainability initiatives and performance. Areas of focus include our consumers, our communities, our associates and our environment, as briefly described below and under Corporate Impact in this Proxy Statement.

More information about our sustainability practices